Incidence and risk factors for developing diabetic retinopathy among youths with type 1 or type 2 diabetes throughout the United States
Ozempic Face is a result of rapid weight loss, and may be related to how GLP-1 drugs, such as Ozempic, affect body composition, in particular, how they reduce muscle mass and affect facial fat
The difference becomes more pronounced with higher-dose injectable semaglutide: Wegovy (2.4 mg weekly) demonstrated mean weight loss of approximately 15% of body weight in the STEP clinical trial program for obesity management, substantially exceeding outcomes typically seen with oral semaglutide at diabetes-approved doses
Chhabra encourages patients to use this first week to practice mindful eating, as the diminished drive to eat allows you to focus on the quality of your nutrition rather than the quantity, setting the stage for long-term behavioral success
Working with your healthcare provider A dosage chart is a reference tool
Download our GLP-1 app to Turn Your Weight Loss Journey into Your Favorite Game
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
